Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effect of Dexmedetomidine in Scheduled Outpatient Surgery
2024-513101-31-00Phase 3Authorised
- Sponsor
- CHU Nîmes
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, sponsored by CHU Nîmes. Planned start Oct 2024; status: authorised.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on 2024-513101-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513101-31-00.